Epidermal Growth Factor from mouse

Description

• General description: Epidermal Growth Factor (EGF) is a small mitogenic polypeptide (∼6kDa) present in many mammalian species and distributed throughout a wide number of tissues and body fluids.[1] Four ErbB (HER) family receptor tyrosine kinases, including EGFR/ErbB1, ErbB2, ErbB3, and ErbB4 mediate responses to EGF family members.[2] Human and mouse EGFs are very similar, but not identical in their physical and chemical properties. Of the 53 amino acid residues comprising each of the two polypeptides, 37 are common to both molecules, and three disulfide bonds are formed in the same relative positions.[3]
• Application: Epidermal Growth Factor from mouse has been used as a basal (N2B27) medium supplement for culturing differentiated mouse embryonic stem (E14) cells.[4]
• Biochem/physiol Actions: EGF (epidermal growth factor) is involved in cellular proliferation, differentiation, and survival.[5] Moreover, it was found to affect various biological activities like angiogenesis, inhibition of gastric acid secretion, modulation of the synthesis of a number of hormones, synthesis and turn-over of proteins of the extracellular matrix, calcium release from bone tissue (thus promoting bone resorption), chemoattraction of fibroblasts and epithelial cells, and alone or in combination with other cytokines, mediation of wound healing processes.[6][7][8][9][10][11][12] EGF is mitogenic for a large variety cell types, including fibroblasts, epithelial cells, endothelial cells, chondrocytes, and SV40-3T3 cells.[3]
• Physical form: The product is lyophilized from a 0.2 μm-filtered solution of phosphate buffered saline (PBS), pH 7.4.
• Citation: 1. Carpenter, G., and Cohen, S., Epidermal growth factor. Annu. Rev. Biochem., 48, 193-216 (1979).2. Jorissen, R.N., et al., Epidermal growth factor: mechanisms of activation and signaling. Exp. Cell Res., 284, 31-53 (2003).3. Herbst, R.S., Review of epidermal growth factor receptor biology. Int.J. Radiat. Oncol. Biol., Phys., 59, S21-S26 (2004).4. Mehta, V.B., and Besner, G.E., HB-EGF promotes angiogenesis in endothelial cells via PI3-kinase and MAPK signaling pathways. Growth Factors, 25, 253-263 (2007). 5. Bower, J.M., et al., The inhibition of gastric acid secretion by epidermal growth factor. Experientia, 31, 825-826 (1975). 6. Schonbrunn, A., et.al., Epidermal growth factor and thyrotropin-releasing hormone act similarly on a clonal pituitary cell strain. Modulation of hormone production and inhibition of cell proliferation. J. Cell Biol., 85, 786-797 (1980).7. Mimura, Y., et al., Epidermal growth factor induces fibronectin expression in human dermal fibroblasts via protein kinase C delta signaling pathway. J. Invest. Dermatol., 122, 1390-1398 (2004).8. Warner, M.R. et al., Ametantrone inhibits prostaglandin-mediated resorption in bone organ culture. Prostaglandins, 28, 469-476 (1984).9. Grotendorst, G.R., et al., EGF and TGF-alpha are potent chemoattractants for endothelial cells and EGF-like peptides are present at sites of tissue regeneration. J. Cell. Physiol., 139, 617623 (1989).10. Schultz, G., et al., EGF and TGF-alpha in wound healing and repair. J. Cell. Biochem., 45, 346-352 (1991).11. George-Nascimento, C., et al., Characterization of recombinant human epidermal growth factor produced in yeast. Biochemistry, 27, 797-802 (1988).